Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Celgene initiates development of Thalomid for hematological cancers

Sep. 30, 1998

Pharmacyclics starts phase III Gd-Tex trial for brain metastases

Sep. 28, 1998

Polish researchers present new antitumor agents

Sep. 28, 1998

Investigators at C&C Research design new antiestrogenic agents

Sep. 28, 1998

HMR grants Matrix rights to anticancer agent about to enter phase II

Sep. 25, 1998

Oxigene updates Neu-Sensamide development status

Sep. 25, 1998

Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine

Sep. 24, 1998

New paclitaxel formulation enters clinical trials

Sep. 24, 1998

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Sep. 24, 1998

Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...